Return on Equity (ROE)
since 2005
Calculation
Cigna Group, ROE, long-term trends, calculation
| ROE | = | 100 | × | Shareholders’ net income1 | ÷ | Shareholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 8.37% | = | 100 | × | 3,434) | ÷ | 41,033) |
| Dec 31, 2023 | 11.17% | = | 100 | × | 5,164) | ÷ | 46,223) |
| Dec 31, 2022 | 14.86% | = | 100 | × | 6,668) | ÷ | 44,872) |
| Dec 31, 2021 | 11.39% | = | 100 | × | 5,365) | ÷ | 47,112) |
| Dec 31, 2020 | 16.81% | = | 100 | × | 8,458) | ÷ | 50,321) |
| Dec 31, 2019 | 11.26% | = | 100 | × | 5,104) | ÷ | 45,338) |
| Dec 31, 2018 | 6.43% | = | 100 | × | 2,637) | ÷ | 41,028) |
| Dec 31, 2017 | 16.32% | = | 100 | × | 2,237) | ÷ | 13,711) |
| Dec 31, 2016 | 13.60% | = | 100 | × | 1,867) | ÷ | 13,723) |
| Dec 31, 2015 | 17.40% | = | 100 | × | 2,094) | ÷ | 12,035) |
| Dec 31, 2014 | 19.51% | = | 100 | × | 2,102) | ÷ | 10,774) |
| Dec 31, 2013 | 13.97% | = | 100 | × | 1,476) | ÷ | 10,567) |
| Dec 31, 2012 | 16.61% | = | 100 | × | 1,623) | ÷ | 9,769) |
| Dec 31, 2011 | 15.90% | = | 100 | × | 1,327) | ÷ | 8,344) |
| Dec 31, 2010 | 20.24% | = | 100 | × | 1,345) | ÷ | 6,645) |
| Dec 31, 2009 | 24.04% | = | 100 | × | 1,302) | ÷ | 5,417) |
| Dec 31, 2008 | 8.13% | = | 100 | × | 292) | ÷ | 3,592) |
| Dec 31, 2007 | 23.48% | = | 100 | × | 1,115) | ÷ | 4,748) |
| Dec 31, 2006 | 26.67% | = | 100 | × | 1,155) | ÷ | 4,330) |
| Dec 31, 2005 | 30.32% | = | 100 | × | 1,625) | ÷ | 5,360) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
- Shareholders’ Net Income Trends
- The net income exhibits significant volatility throughout the periods. Initially, it decreases sharply from 1625 million USD in 2005 to a low of 292 million USD in 2008, likely impacted by economic factors during that time. Subsequently, the income recovers and fluctuates moderately between approximately 1300 and 2700 million USD through 2014. The period from 2015 to 2017 shows strong growth, peaking at 5104 million USD in 2019. Notably, net income reaches a very high point at 8458 million USD in 2020, followed by a sharp decline to 5164 million USD by 2023, and further down to 3434 million USD in 2024. This indicates periods of both pronounced growth and contraction, reflecting some operational or market challenges in recent years.
- Shareholders’ Equity Trends
- Shareholders’ equity generally trends upwards over the analyzed period. It starts at 5360 million USD in 2005 and experiences some fluctuations early on, decreasing to 3592 million USD by 2008. From 2009 onwards, equity grows steadily, reaching a substantial peak of 50321 million USD in 2020. However, after this peak, equity declines moderately to approximately 41033 million USD by 2024. This pattern suggests strong capital accumulation over the medium term with some retrenchment in the most recent years.
- Return on Equity (ROE) Patterns
- ROE demonstrates a declining trend from an initially high 30.32% in 2005 down to 8.13% in 2008, mirroring the downturn in net income seen in the same period. It then stabilizes somewhat between 13% and 20% for much of the following decade, with a notable dip to 6.43% in 2018. The metric then rises again but remains moderate, fluctuating around 11% to 16% from 2019 through 2022. In recent periods, ROE falls to 8.37% by 2024, indicating reduced profit generation efficiency relative to shareholders’ equity.
- Overall Financial Performance Insights
- The data reveals an entity experiencing considerable financial volatility with periods of strong earnings growth and increased equity capital, contrasted by episodes of income decline and lower returns on equity. The sharp spikes in net income, particularly in 2020, followed by declines, suggest possible extraordinary gains or changes in operational performance. The sustained growth in equity through most of the period implies reinvestment of earnings or capital raises, although recent declines in equity and ROE could signal challenges in maintaining profitability or capital efficiency. The downward trend in ROE despite historically high equity levels warrants attention to operational leverage and profit margins going forward.
Comparison to Competitors
Cigna Group, ROE, long-term trends, comparison to competitors
| Cigna Group | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2024 | 8.37% | 28.12% | 14.47% | 14.13% | 7.32% | 15.55% |
| Dec 31, 2023 | 11.17% | 14.83% | 15.23% | 13.51% | 7.30% | 25.22% |
| Dec 31, 2022 | 14.86% | 18.90% | 16.59% | 11.98% | 9.59% | 25.87% |
| Dec 31, 2021 | 11.39% | 19.75% | 16.93% | 14.32% | 7.01% | 24.09% |
| Dec 31, 2020 | 16.81% | 13.71% | 13.77% | 10.90% | 9.44% | 23.52% |
| Dec 31, 2019 | 11.26% | 11.86% | 15.15% | 16.69% | 9.25% | 24.02% |
| Dec 31, 2018 | 6.43% | 7.76% | 13.14% | 16.89% | 6.12% | 23.19% |
| Dec 31, 2017 | 16.32% | 1.54% | 14.50% | 13.97% | 8.01% | 22.10% |
| Dec 31, 2016 | 13.60% | 6.82% | 9.84% | 12.74% | 6.80% | 18.33% |
| Dec 31, 2015 | 17.40% | 20.85% | 11.11% | 13.63% | 5.03% | 17.18% |
| Dec 31, 2014 | 19.51% | 10.61% | 10.60% | 12.39% | 15.76% | 17.31% |
| Dec 31, 2013 | 13.97% | 10.23% | 10.05% | 19.16% | 18.57% | 17.50% |
| Dec 31, 2012 | 16.61% | 22.32% | 11.16% | 18.34% | 21.14% | 17.72% |
| Dec 31, 2011 | 15.90% | 19.35% | 11.36% | 18.71% | 19.39% | 18.17% |
| Dec 31, 2010 | 20.24% | 20.66% | 12.12% | 18.74% | 21.18% | 17.94% |
| Dec 31, 2009 | 24.04% | 25.14% | 19.09% | 15.13% | 16.88% | 16.19% |
| Dec 31, 2008 | 8.13% | 27.92% | 11.62% | 16.13% | 19.34% | 14.33% |
| Dec 31, 2007 | 23.48% | 20.28% | 14.55% | 16.26% | 25.53% | 23.20% |
| Dec 31, 2006 | 26.67% | 12.22% | 12.59% | 12.22% | 27.14% | 19.99% |
| Dec 31, 2005 | 30.32% | 23.39% | 9.86% | 21.27% | 17.26% | 18.61% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Cigna Group, ROE, long-term trends, comparison to sector (health care equipment & services)
| Cigna Group | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2024 | 8.37% | 16.02% |
| Dec 31, 2023 | 11.17% | 17.13% |
| Dec 31, 2022 | 14.86% | 18.40% |
| Dec 31, 2021 | 11.39% | 17.28% |
| Dec 31, 2020 | 16.81% | 15.80% |
| Dec 31, 2019 | 11.26% | 15.85% |
| Dec 31, 2018 | 6.43% | 13.28% |
| Dec 31, 2017 | 16.32% | 12.21% |
| Dec 31, 2016 | 13.60% | 10.70% |
| Dec 31, 2015 | 17.40% | 11.84% |
| Dec 31, 2014 | 19.51% | 13.81% |
| Dec 31, 2013 | 13.97% | 14.22% |
| Dec 31, 2012 | 16.61% | 17.99% |
| Dec 31, 2011 | 15.90% | 17.02% |
| Dec 31, 2010 | 20.24% | 17.62% |
| Dec 31, 2009 | 24.04% | 19.50% |
| Dec 31, 2008 | 8.13% | 17.63% |
| Dec 31, 2007 | 23.48% | 20.02% |
| Dec 31, 2006 | 26.67% | 16.70% |
| Dec 31, 2005 | 30.32% | 16.22% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cigna Group, ROE, long-term trends, comparison to industry (health care)
| Cigna Group | Health Care | |
|---|---|---|
| Dec 31, 2024 | 8.37% | 15.74% |
| Dec 31, 2023 | 11.17% | 19.40% |
| Dec 31, 2022 | 14.86% | 24.82% |
| Dec 31, 2021 | 11.39% | 25.44% |
| Dec 31, 2020 | 16.81% | 16.70% |
| Dec 31, 2019 | 11.26% | 23.30% |
| Dec 31, 2018 | 6.43% | 21.27% |
| Dec 31, 2017 | 16.32% | 13.77% |
| Dec 31, 2016 | 13.60% | 18.53% |
| Dec 31, 2015 | 17.40% | 18.52% |
| Dec 31, 2014 | 19.51% | 19.17% |
| Dec 31, 2013 | 13.97% | 18.81% |
| Dec 31, 2012 | 16.61% | 18.20% |
| Dec 31, 2011 | 15.90% | 15.90% |
| Dec 31, 2010 | 20.24% | 14.85% |
| Dec 31, 2009 | 24.04% | 20.14% |
| Dec 31, 2008 | 8.13% | 20.29% |
| Dec 31, 2007 | 23.48% | 17.87% |
| Dec 31, 2006 | 26.67% | 20.49% |
| Dec 31, 2005 | 30.32% | 18.28% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).